4.0 Article

User testing and performance evaluation of the Electronic Quality Improvement Platform for Plans and Pharmacies

Journal

JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
Volume 55, Issue 6, Pages 634-641

Publisher

AMER PHARMACEUTICAL ASSOC
DOI: 10.1331/JAPhA.2015.15074

Keywords

-

Funding

  1. Takeda Pharmaceuticals International, Inc.

Ask authors/readers for more resources

Objective: To user-test and evaluate a performance information management platform that makes standardized, benchmarked medication use quality data available to both health plans and community pharmacy organizations. Setting: Multiple health/drug plans and multiple chain and independent pharmacies across the United States. Evaluation: During the first phase of the study, user experience was measured via user satisfaction surveys and interviews with key personnel (pharmacists, pharmacy leaders, and health plan leadership). Improvements were subsequently made to the platform based on these findings. During the second phase of the study, the platform was implemented in a greater number of pharmacies and by a greater number of payers. User experience was then reevaluated to gather information for further improvements. Results: The surveys and interviews revealed that users found the Web-based platform easy to use and beneficial in terms of understanding and comparing performance metrics. Primary concerns included lack of access to real-time data and patient-specific data. Many users also expressed uncertainty as to how they could use the information and data provided by the platform. Conclusion: The study findings indicate that while information management platforms can be used effectively in both pharmacy and health plan settings, future development is needed to ensure that the provided data can be transferred to pharmacy best practices and improved quality care.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available